Total Payments
$8,579
2023 Payments
$125.63
Companies
32
Transactions
376
Medicare Patients
1,549
Medicare Billing
$85,736
Payment Breakdown by Category
Food & Beverage$7,147 (83.3%)
Consulting$1,377 (16.1%)
Education$55.19 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,147 | 371 | 83.3% |
| Consulting Fee | $1,377 | 2 | 16.1% |
| Education | $55.19 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,910 | 68 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,620 | 100 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $750.35 | 32 | $0 (2022) |
| Mylan Specialty L.P. | $439.76 | 26 | $0 (2023) |
| Philips Electronics North America Corporation | $404.80 | 19 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $318.56 | 16 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $313.19 | 13 | $0 (2021) |
| Genentech USA, Inc. | $299.42 | 16 | $0 (2021) |
| Jazz Pharmaceuticals Inc. | $191.03 | 10 | $0 (2020) |
| Grifols USA, LLC | $177.94 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $125.63 | 7 | GENZYME CORPORATION ($34.36) |
| 2022 | $26.17 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13.48) |
| 2021 | $44.83 | 3 | Genentech USA, Inc. ($16.24) |
| 2020 | $1,055 | 59 | GlaxoSmithKline, LLC. ($186.39) |
| 2019 | $2,155 | 110 | AstraZeneca Pharmaceuticals LP ($463.39) |
| 2018 | $2,272 | 104 | AstraZeneca Pharmaceuticals LP ($728.59) |
| 2017 | $2,900 | 91 | AstraZeneca Pharmaceuticals LP ($1,558) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: PAH | ||||||
| 05/11/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Medical Device | ||||||
| 05/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Immunology | ||||||
| 04/18/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Immunology | ||||||
| 03/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiology | ||||||
| 12/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2021 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Immunology | ||||||
| 04/29/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/22/2021 | HARMONY BIOSCIENCES LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: Neurological Disorders | ||||||
| 09/15/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 07/20/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $20.22 | General |
| Category: Dental and Oral Health | ||||||
| 07/13/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/10/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Respiratory | ||||||
| 06/03/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Dental and Oral Health | ||||||
| 05/29/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NEUROLOGY | ||||||
| 05/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2020 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: Neurological Disorders | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 149 | 171 | $26,656 | $9,617 |
| 2022 | 7 | 323 | 381 | $55,946 | $23,126 |
| 2021 | 8 | 462 | 604 | $57,162 | $25,977 |
| 2020 | 11 | 615 | 661 | $68,041 | $27,016 |
Total Patients
1,549
Total Services
1,817
Medicare Billing
$85,736
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 47 | $8,012 | $3,128 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 32 | 53 | $7,473 | $2,535 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 28 | 28 | $5,236 | $1,612 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,460 | $1,199 | 48.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 16 | 16 | $1,840 | $620.74 | 33.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 15 | 15 | $1,635 | $522.80 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 103 | $28,130 | $10,807 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 167 | $22,832 | $10,422 | 45.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,294 | $898.82 | 39.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 14 | 14 | $882.00 | $333.71 | 37.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 29 | 29 | $667.00 | $261.62 | 39.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 27 | 27 | $648.00 | $208.96 | 32.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 29 | 29 | $493.00 | $195.09 | 39.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 246 | $32,102 | $15,294 | 47.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 52 | 52 | $9,770 | $4,265 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 37 | $7,040 | $3,595 | 51.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 42 | 45 | $2,835 | $1,089 | 38.4% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 67 | 72 | $1,952 | $650.76 | 33.3% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 71 | 74 | $1,510 | $504.10 | 33.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 60 | 61 | $1,640 | $475.02 | 29.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 16 | 17 | $313.00 | $104.64 | 33.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 173 | 191 | $22,701 | $8,168 | 36.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 85 | 94 | $8,545 | $5,648 | 66.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 71 | $12,471 | $4,591 | 36.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $7,551 | $2,572 | 34.1% |
About Dr. Gary Drizin, MD
Dr. Gary Drizin, MD is a Pulmonary Disease healthcare provider based in Twin Falls, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700848140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Drizin, MD has received a total of $8,579 in payments from pharmaceutical and medical device companies, with $125.63 received in 2023. These payments were reported across 376 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,147).
As a Medicare-enrolled provider, Drizin has provided services to 1,549 Medicare beneficiaries, totaling 1,817 services with total Medicare billing of $85,736. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Twin Falls, ID
- Active Since 04/03/2006
- Last Updated 03/26/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1700848140
Products in Payments
- SYMBICORT (Drug) $808.43
- TRELEGY ELLIPTA (Drug) $553.91
- FASENRA (Drug) $539.01
- NUCALA (Biological) $469.59
- ACTHAR (Biological) $397.64
- BEVESPI AEROSPHERE (Drug) $328.24
- DUPIXENT (Biological) $317.35
- BREO (Drug) $314.73
- OFEV (Drug) $296.32
- ANORO (Drug) $241.45
- Perforomist (Drug) $228.33
- STIOLTO RESPIMAT (Drug) $203.45
- Xolair (Biological) $176.53
- Yupelri (Drug) $167.02
- (8874) inCourage (Device) $136.73
- Esbriet (Biological) $122.89
- ELIQUIS (Drug) $119.13
- Prolastin-C (Biological) $108.99
- XYREM (Drug) $103.18
- Arikayce (Drug) $101.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.